Why this drug-research company’s stock is having its worst day since 1999

Published: Feb. 12, 2026 at 11:10 a.m. ET Shares of Icon were plummeting on Thursday toward their…

20 stocks of companies that delivered a double dose of growth this earnings season

Published: Feb. 11, 2026 at 10:45 a.m. ET Each earnings season, most companies will report earnings per…

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to…

Morgan Stanley just poured through 3,600 stocks and says these are the best opportunities from the AI shakeout

Morgan Stanley strategists offer criteria on how to find the AI winners, saying the market is…

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill,…

AstraZeneca profit climbs on cancer and heart drug demand

The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on…

Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor

Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed…

Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill

Published: Feb. 6, 2026 at 3:29 p.m. ET Hims & Hers Health’s stock was on track to…

Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food…

TrumpRx is here. Here’s why it will not lower drug prices for most Americans.

Last Updated: Feb. 5, 2026 at 7:22 p.m. ETFirst Published: Feb. 5, 2026 at 4:17 p.m. ET TrumpRx,…